Coherus Oncology, Inc. · NASDAQ:CHRS
BlackRock, Inc. reported a 9.60% stake in Coherus Oncology, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 5, 2025
BlackRock, Inc. reported a 9.60% stake in Coherus Oncology, Inc., 11,075,915 shares, as a passive investor on Dec 31, 2024. Filed Feb 5, 2025 (Schedule 13G/A).
- Stake
- 9.60%
- Shares
- 11,075,915
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 9.60% | 11,075,915 |
Source
Related
- Coherus Oncology, Inc.
- BlackRock, Inc.
- Coherus Oncology, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 27, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 17, 2025
- Form 4 · Satvat Ali J. · Jun 9, 2026
- Form 4 · Karachun Rita A · Jun 9, 2026
- Form 4 · Newcomer Lee Nisley · Jun 9, 2026
- Form 4 · Ryan Michael Lee · Jun 9, 2026
- Form 4 · O'Donnell-Tormey Jill · Jun 9, 2026